TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34546088

Group type: COMPARATOR
Intervention: Routine once-daily rehabilitation training without HBO (Control)
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Routine once-daily rehabilitation training with HBO (Study Group A)
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Twice-daily intensified rehabilitation training with HBO (Study Group B)
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Twice-daily intensified rehabilitation training without HBO (Study Group C)
Number of subjects: 158
Study: 35543013

Group type: EXPERIMENTAL
Intervention: Working Memory‐based Cognitive Rehabilitation (WMCR) intervention, 11 sessions
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 28
Study: 33709484

Group type: EXPERIMENTAL
Intervention: Forgiveness Therapy for 24 weeks
Number of subjects: 24

Group type: COMPARATOR
Intervention: Alternative treatment for 24 weeks followed by Forgiveness Therapy
Number of subjects: 24
Study: 32040492

Group type: EXPERIMENTAL
Intervention: Intervention group (n = 19) - instructed to avoid using mobile phone 30 minutes before bedtime.
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (n = 19) - no instructions regarding mobile phone use before bedtime.
Number of subjects: 38
Study: 32772853

Group type: EXPERIMENTAL
Intervention: Psychological intervention programme
Number of subjects: 154
Study: 32056414

Group type: EXPERIMENTAL
Intervention: Charisma Opal Flow with self-etch
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: G-aenial Universal Flo with self-etch
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Charisma Opal Flow with etch&rinse
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: G-aenial Universal Flo with etch&rinse
Number of subjects: 100
Study: 33419442

Group type: EXPERIMENTAL
Intervention: P.A.C.E. training program
Number of subjects: 171

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 171
Study: 32962898

Group type: EXPERIMENTAL
Intervention: Nurse-led consultations plus peer-led telephone sessions
Number of subjects: 319

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 319
Study: 35854250

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy adapted for GAD (MBCT-A)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Cognitive behavioural therapy adapted for GAD (CBT-A)
Number of subjects: 138
Study: 34403326

Group type: EXPERIMENTAL
Intervention: Isoniazid 5 mg/kg (normal dose)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Isoniazid 10 mg/kg
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Isoniazid 15 mg/kg
Number of subjects: 59
Study: 35390722

Group type: EXPERIMENTAL
Intervention: Expectation-confirmation condition (n = 34)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Expectation-disconfirmation condition (n = 39)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Both groups with large expectation violations
Number of subjects: 73
Study: 33761464

Group type: EXPERIMENTAL
Intervention: Incremental Aerobic Training (IAT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Traditional pulmonary rehabilitation program (Control)
Number of subjects: 30
Study: 34309028

Group type: EXPERIMENTAL
Intervention: New personalized nomogram incorporating height, weight, and hematocrit
Number of subjects: 3443

Group type: COMPARATOR
Intervention: Established weight‐based nomogram (control)
Number of subjects: 3443

Group type: EXPERIMENTAL
Intervention: Control and experimental arms (combined)
Number of subjects: 3443
Study: 32474683

Group type: EXPERIMENTAL
Intervention: Whole-body cryotherapy at -110 °C
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Whole-body cryotherapy at -110 °C (1st session)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Whole-body cryotherapy at -110 °C (5th session)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control temperature (≃ 24 °C)
Number of subjects: 40
Study: 34024872

Group type: EXPERIMENTAL
Intervention: Japan Diet (JD)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Partial Japan Diet (PJD)
Number of subjects: 98
Study: 33341984

Group type: COMPARATOR
Intervention: NHSBT's customary method
Number of subjects: 21840

Group type: EXPERIMENTAL
Intervention: Post donation approach
Number of subjects: 21840

Group type: EXPERIMENTAL
Intervention: Portable haemoglobinometry
Number of subjects: 21840

Group type: EXPERIMENTAL
Intervention: Non-invasive spectrometry (MBR Haemospect or Orsense NMB200)
Number of subjects: 21840
Study: 32726408

Group type: EXPERIMENTAL
Intervention: 0.2 mg/kg ketamine
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg ketamine
Number of subjects: 48

Group type: COMPARATOR
Intervention: Saline placebo infusion
Number of subjects: 48
Study: 34343556

Group type: EXPERIMENTAL
Intervention: Tree Canopy Coverage (TCC)
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Increase in TCC by 1%
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: COVID-19 epidemic impact
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Antagonism joint action between TCC and COVID-19
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Correlation of GHQ items and TCC
Number of subjects: 900
Study: 35821552

Group type: EXPERIMENTAL
Intervention: Educational intervention by clinical pharmacist
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard medical care (control)
Number of subjects: 120
Study: 32007334

Group type: EXPERIMENTAL
Intervention: 8-week lifestyle intervention
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Baseline telomere length (TL)
Number of subjects: 106
Study: 34486933

Group type: EXPERIMENTAL
Intervention: Pentacam
Number of subjects: 5620

Group type: COMPARATOR
Intervention: Biograph
Number of subjects: 5620

Group type: EXPERIMENTAL
Intervention: Pentacam and Biograph
Number of subjects: 5620
Study: 34105868

Group type: EXPERIMENTAL
Intervention: Grinding with diamond burs
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Polishing (with or without glazing)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Glazing
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Grinding followed by polishing
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Grinding followed by glazing
Number of subjects: 5
Study: 32845862

Group type: EXPERIMENTAL
Intervention: Nutrition education programme (30 min)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Pamphlets regarding healthy dietary intake
Number of subjects: 150
Study: 36116454

Group type: EXPERIMENTAL
Intervention: Single CT colonography
Number of subjects: 14981

Group type: COMPARATOR
Intervention: Three rounds of faecal immunochemical test (FIT)
Number of subjects: 14981
Study: 34543941

Group type: EXPERIMENTAL
Intervention: Chemotherapy + Denosumab
Number of subjects: 740

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 740

Group type: EXPERIMENTAL
Intervention: Chemotherapy + Denosumab (subgroup: squamous histology)
Number of subjects: 740
Study: 35094790

Group type: EXPERIMENTAL
Intervention: Oseltamivir
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: VAS (Visual Analog Scale)
Number of subjects: 0
Study: 33725832

Group type: EXPERIMENTAL
Intervention: Ultrasound + LLLT
Number of subjects: 0

Group type: COMPARATOR
Intervention: LLLT
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ultrasound
Number of subjects: 0
Study: 36497790

Group type: EXPERIMENTAL
Intervention: Controlled physical training with whirlpool massage (10 lower-limb whirling massages and individually planned training)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Individually planned training (control group)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Controlled physical training with whirlpool massage
Number of subjects: 100
Study: 36231891

Group type: EXPERIMENTAL
Intervention: Mobile app
Number of subjects: 118

Group type: COMPARATOR
Intervention: Booklet
Number of subjects: 118

Group type: COMPARATOR
Intervention: Control
Number of subjects: 118
Study: 34574673

Group type: EXPERIMENTAL
Intervention: Flipped teaching method
Number of subjects: 85

Group type: COMPARATOR
Intervention: Traditional teaching method (Control)
Number of subjects: 85
Study: 35037373

Group type: EXPERIMENTAL
Intervention: One avocado daily for 8 weeks
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (habitual diet)
Number of subjects: 39
Study: 34080265

Group type: EXPERIMENTAL
Intervention: Cosmos caudatus (CC) supplementation (two 500 mg capsules daily for 12 weeks)
Number of subjects: 20
Study: 32023901

Group type: EXPERIMENTAL
Intervention: Yogurt containing more than 5 × 10^9 heat‐treated OLL2712 cells
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo (conventional yogurt)
Number of subjects: 130
Study: 33443905

Group type: EXPERIMENTAL
Intervention: Prehabilitation (3-week community-based exercise program, 3 sessions per week, 9 sessions total)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 57
Study: 33847614

Group type: EXPERIMENTAL
Intervention: Shenhuang plaster application on shenque point (CV8) plus chemotherapy treatment
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo plaster application on CV8 plus chemotherapy treatment
Number of subjects: 160
Study: 34183087

Group type: EXPERIMENTAL
Intervention: Tablet-based intervention (TBI)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Conventional activity sessions (CAS)
Number of subjects: 162
Study: 32114586

Group type: EXPERIMENTAL
Intervention: Conventional therapy plus edaravone for 2 weeks
Number of subjects: 96

Group type: COMPARATOR
Intervention: Conventional therapy alone for 2 weeks
Number of subjects: 96
Study: 34308735

Group type: EXPERIMENTAL
Intervention: Zi Gui Nv Zhen® capsules (ZGNZC)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Control group (no ZGNZC)
Number of subjects: 109
Study: 33516752

Group type: EXPERIMENTAL
Intervention: Icosapent ethyl (IPE) 2 grams by mouth twice daily with meals
Number of subjects: 16500

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 16500
Study: 32636109

Group type: COMPARATOR
Intervention: 10‐mg dexamethasone (1 dose)
Number of subjects: 150

Group type: COMPARATOR
Intervention: 10‐mg dexamethasone (2 doses)
Number of subjects: 150

Group type: COMPARATOR
Intervention: 10‐mg dexamethasone (3 doses)
Number of subjects: 150
Study: 36257266

Group type: EXPERIMENTAL
Intervention: CCP-enriched bread (30% wheat flour replaced by CCP)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: CCP-enriched bread (60% wheat flour replaced by CCP)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (0% wheat flour replaced by CCP)
Number of subjects: 20
Study: 34620309

Group type: EXPERIMENTAL
Intervention: White tea
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Aerobic training
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Aerobic training + white tea
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 49
Study: 32486007

Group type: EXPERIMENTAL
Intervention: Whey protein isolate (19 grams)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Soy protein isolate (26 grams)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Both groups (Whey and Soy)
Number of subjects: 61
Study: 35297178

Group type: EXPERIMENTAL
Intervention: 3D animation + cadaveric video
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: 3D animation
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Cadaveric video
Number of subjects: 168

Group type: COMPARATOR
Intervention: Textbook
Number of subjects: 168
Study: 33145834

Group type: EXPERIMENTAL
Intervention: Methylene blue-mediated photodynamic therapy (MB-PDT)
Number of subjects: 27

Group type: COMPARATOR
Intervention: 5% amorolfine nail lacquer (AMO)
Number of subjects: 27
Study: 37274852

Group type: EXPERIMENTAL
Intervention: Cognitive Remediation Virtual Reality Program (CEREBRUM), 3 months with 2 weekly sessions
Number of subjects: 50

Group type: COMPARATOR
Intervention: Usual care program (psychiatric visit and/or psychotherapy)
Number of subjects: 50
Study: 36045306

Group type: EXPERIMENTAL
Intervention: Kinesio taping with conventional physical therapy (CPT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional physical therapy (CPT) only
Number of subjects: 60
Study: 33158590

Group type: EXPERIMENTAL
Intervention: Ready-to-drink protein shakes (PRO; n = 25)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Standard-of-care recommendations (SOC; n = 24)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Both groups (PRO and SOC)
Number of subjects: 49
Study: 32048804

Group type: EXPERIMENTAL
Intervention: Hb E heterozygotes
Number of subjects: 698

Group type: EXPERIMENTAL
Intervention: Hb E homozygotes
Number of subjects: 698

Group type: COMPARATOR
Intervention: Non-Hb E group
Number of subjects: 698

Group type: EXPERIMENTAL
Intervention: Comparison of children with and without an α-gene defect
Number of subjects: 698

Group type: EXPERIMENTAL
Intervention: Age and sex
Number of subjects: 698
Study: 36195890

Group type: EXPERIMENTAL
Intervention: SAIA implementation strategy
Number of subjects: 144

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 144
Study: 32311700

Group type: EXPERIMENTAL
Intervention: 400 IU vitamin D3/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 4400 IU vitamin D3/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 32589977

Group type: EXPERIMENTAL
Intervention: Selinexor 60 mg orally on days 1 and 3 weekly until disease progression or unacceptable toxicity
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Selinexor 60 mg
Number of subjects: 127
Study: 34311951

Group type: EXPERIMENTAL
Intervention: Core needle biopsy (CNB)
Number of subjects: 65

Group type: COMPARATOR
Intervention: No core needle biopsy (no CNB)
Number of subjects: 65
Study: 34097911

Group type: EXPERIMENTAL
Intervention: Cytokine adsorption
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 32456804

Group type: EXPERIMENTAL
Intervention: ASP3652 30-900 mg single dose
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: ASP3652 100-300 mg BID multiple doses
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study: 34271229

Group type: EXPERIMENTAL
Intervention: Flax+Met
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Flax+Cho
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control
Number of subjects: 96
Study: 35546221

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acupoint stimulation (TEAS)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Sham TEAS
Number of subjects: 97
Study: 33818620

Group type: EXPERIMENTAL
Intervention: Packed red blood cell (PRBC) transfusion
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Expert consensus guideline
Number of subjects: 39
Study: 35481952

Group type: EXPERIMENTAL
Intervention: Active recovery (pedaling at 50 rpm at 20% of sprint workload)
Number of subjects: 15

Group type: COMPARATOR
Intervention: BEMER recovery (laying supine on the BEMER body pad at intensity level '5-Plus')
Number of subjects: 15

Group type: COMPARATOR
Intervention: Passive recovery (laying supine)
Number of subjects: 15
Study: 34548116

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (stationary cycling) performed daily for 1 week
Number of subjects: 3

Group type: COMPARATOR
Intervention: Non-aerobic exercise (stretching and calisthenics) performed daily for 1 week
Number of subjects: 3

Group type: COMPARATOR
Intervention: Non-injured reference group
Number of subjects: 3
Study: 35667725

Group type: EXPERIMENTAL
Intervention: Telehealth delivered exercise and nutrition intervention
Number of subjects: 104

Group type: COMPARATOR
Intervention: Clinic-based exercise and nutrition intervention
Number of subjects: 104
Study: 36243129

Group type: EXPERIMENTAL
Intervention: Gabapentin 600 mg
Number of subjects: 126

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 126
Study: 35545464

Group type: EXPERIMENTAL
Intervention: ModuS‐T program (youth-specific group education program)
Number of subjects: 181

Group type: COMPARATOR
Intervention: Control group (no program)
Number of subjects: 181
Study: 32501613

Group type: EXPERIMENTAL
Intervention: Physical activity intervention
Number of subjects: 499
Study: 34634364

Group type: EXPERIMENTAL
Intervention: Baseline ocular biometric measurements (AOD500, IC, age)
Number of subjects: 643

Group type: EXPERIMENTAL
Intervention: Lowest quartile of horizontal AOD500 and IC measurements, age 59 years or older
Number of subjects: 643

Group type: COMPARATOR
Intervention: Cumulative gonioscopy score
Number of subjects: 643
Study: 34763506

Group type: EXPERIMENTAL
Intervention: Dialectical behavior therapy intervention for 4 weeks
Number of subjects: 26

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 26
Study: 33051871

Group type: EXPERIMENTAL
Intervention: Biological mesh
Number of subjects: 24

Group type: COMPARATOR
Intervention: Synthetic mesh
Number of subjects: 24
Study: 33249142

Group type: EXPERIMENTAL
Intervention: Low-Dose Radiation Therapy (LD-RT) at 100 cGy to total lungs in a single fraction
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 9
Study: 35966250

Group type: EXPERIMENTAL
Intervention: Dapagliflozin combined with metoprolol sustained-release tablets (Group A)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Dapagliflozin (Group B)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo (Group C)
Number of subjects: 84
Study: 34173640

Group type: EXPERIMENTAL
Intervention: Uroflowmetry and post‐void ultrasound bladder scanning in primary care
Number of subjects: 344

Group type: COMPARATOR
Intervention: Standard care without uroflowmetry and post‐void ultrasound bladder scanning
Number of subjects: 344
Study: 32197277

Group type: EXPERIMENTAL
Intervention: Inclisiran (300 mg subcutaneous injections on days 1, 90, 270, and 450)
Number of subjects: 482

Group type: COMPARATOR
Intervention: Placebo (matching injections on the same schedule)
Number of subjects: 482

Group type: EXPERIMENTAL
Intervention: Inclisiran (300 mg)
Number of subjects: 482

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 482
Study: 36163867

Group type: EXPERIMENTAL
Intervention: Ibr+Ven
Number of subjects: 211

Group type: COMPARATOR
Intervention: Clb+O
Number of subjects: 211
Study: 36354038

Group type: EXPERIMENTAL
Intervention: Weight-adjusted intermediate-dose low-molecular-weight heparin
Number of subjects: 1110

Group type: COMPARATOR
Intervention: Fixed low-dose low-molecular-weight heparin
Number of subjects: 1110
Study: 32361668

Group type: EXPERIMENTAL
Intervention: Upward Assimilation (UA) manipulation
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Downward Assimilation (DA) manipulation
Number of subjects: 159

Group type: COMPARATOR
Intervention: Control condition (no manipulation of social comparison)
Number of subjects: 159
Study: 34546390

Group type: EXPERIMENTAL
Intervention: Single pre‐incision tranexamic acid bolus of one gram (Group A)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Double tranexamic acid dose regimen (Group B)
Number of subjects: 61
Study: 32057487

Group type: EXPERIMENTAL
Intervention: Digital workflow
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional workflow
Number of subjects: 40
Study: 32773484

Group type: EXPERIMENTAL
Intervention: Universal Testing and Treatment (UTT)
Number of subjects: 8747

Group type: COMPARATOR
Intervention: Arm A (UTT)
Number of subjects: 8747

Group type: COMPARATOR
Intervention: Arm B (UTT)
Number of subjects: 8747

Group type: EXPERIMENTAL
Intervention: All arms
Number of subjects: 8747
Study: 34057550

Group type: EXPERIMENTAL
Intervention: Dichoptic VR video games, played for 1 hour per week under supervision
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Dichoptic VR video games
Number of subjects: 91
Study: 32944790

Group type: EXPERIMENTAL
Intervention: Alcohol (0.80 g/kg)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Active placebo (0.04 g/kg)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Non-alcoholic control beverage
Number of subjects: 96
Study: 34004189

Group type: EXPERIMENTAL
Intervention: Intramuscular vitamin A 5000 IU 3 times weekly for 4 weeks
Number of subjects: 807

Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 807
Study: 32222255

Group type: EXPERIMENTAL
Intervention: Auscultation using a stethoscope
Number of subjects: 60

Group type: COMPARATOR
Intervention: Umbilical cord palpation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both methods (auscultation and palpation)
Number of subjects: 60
Study: 36063757

Group type: EXPERIMENTAL
Intervention: Gamma musical-electrical TNS
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Beta musical-electrical TNS
Number of subjects: 63

Group type: COMPARATOR
Intervention: Sham musical-electrical TNS
Number of subjects: 63
Study: 33385184

Group type: EXPERIMENTAL
Intervention: Guava group (GG)
Number of subjects: 399

Group type: COMPARATOR
Intervention: Banana group (BG)
Number of subjects: 399

Group type: COMPARATOR
Intervention: Cucumber group (CG)
Number of subjects: 399
Study: 35079939

Group type: EXPERIMENTAL
Intervention: Vertical entry sclerotomy (Group 1)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Tunnel entry sclerotomy (Group 2)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 103
Study: 32067777

Group type: EXPERIMENTAL
Intervention: Hyaluronic acid
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Hyaluronic acid plus dexpanthenol
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Isotonic saline
Number of subjects: 240

Group type: COMPARATOR
Intervention: All treatments
Number of subjects: 240
Study: 34411060

Group type: EXPERIMENTAL
Intervention: Droperidol (20 µg/kg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: 0.9% saline (Control)
Number of subjects: 20
Study: 34618630

Group type: COMPARATOR
Intervention: Traditional Surgical Attire (TSA)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Surgical Helmet System (SHS)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Surgical Helmet System with Delayed Ventilation (SHS-DV)
Number of subjects: 180
Study: 35613378

Group type: EXPERIMENTAL
Intervention: STAIR sequence
Number of subjects: 8
Study: 33741234

Group type: EXPERIMENTAL
Intervention: Shared decision-making (SDM) intervention with decision aids (DAs) and decision coaching
Number of subjects: 130

Group type: COMPARATOR
Intervention: Standard educational materials from a health educator (control group)
Number of subjects: 130
Study: 35863553

Group type: EXPERIMENTAL
Intervention: Newly-defined subgroups of type 2 diabetes
Number of subjects: 12738